This inventor holds 1 USPTO granted patent and 5 published patent applications. Top assignee: Oncour Pharma, Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Joseph Podojil: Inventor in Cancer Immunotherapy
Introduction
Joseph Podojil is an inventor associated with Northbrook, Illinois, and Oncour Pharma, Inc. His patent work focuses on approaches to treating immune-evasive cancers.
Latest Patents
Podojil is credited with 1 patent, titled “Treatment of Immune Evasive Tumors.” The disclosure describes methods for treating immune-evasive cancers using surface-functionalized particles, either alone or in combination with cancer therapeutics.
Career Highlights
His listed invention addresses a challenge in cancer treatment: tumors that evade immune responses. The patent describes a particle-based approach intended to be used independently or alongside other cancer therapies.
Collaborations
Podojil’s listed coworkers include John Puisis and Tushar Murthy. His company affiliation is Oncour Pharma, Inc.
Conclusion
Joseph Podojil’s patent work centers on surface-functionalized particles as a potential strategy for treating immune-evasive cancers, including in combination with cancer therapeutics.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile